Epigenetic linkage of aging, cancer and nutrition

Journal of Experimental Biology

Volumn 218, Issue 1, 2015, Pages 59-70

  Daniel, Michael ^a   Tollefsbol, Trygve O ^a,b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Aging; Cancer; Diet; Epigenetics; Nutrition

Indexed keywords

ANIMALIA;

AGING; ANIMAL; CALORIC RESTRICTION; DIET; GENETIC EPIGENESIS; GENETICS; HUMAN; NEOPLASM; NUTRITIONAL STATUS;

AGING; ANIMALS; CALORIC RESTRICTION; DIET; EPIGENESIS, GENETIC; HUMANS; NEOPLASMS; NUTRITIONAL STATUS;

EID: 84926010885     PISSN: 00220949     EISSN: None     Source Type: Journal    
DOI: 10.1242/jeb.107110     Document Type: Review

References (170)

1. Aggarwal, B. B. and Gehlot, P. (2009). Inflammation and cancer: how friendly is the relationship for cancer patients? Curr. Opin. Pharmacol. 9, 351-369.
2. Aggarwal, B. B. and Shishodia, S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71, 1397-1421.
3. Antequera, F. and Bird, A. (1993). Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. USA 90, 11995-11999.
4. Ashizawa, N., Yahata, T., Quan, J., Adachi, S., Yoshihara, K. and Tanaka, K. (2010). Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecol. Oncol. 119, 65-69.
5. Athar, M., Back, J. H., Kopelovich, L., Bickers, D. R. and Kim, A. L. (2009). Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch. Biochem. Biophys. 486, 95-102.
6. Ayissi, V. B., Ebrahimi, A. and Schluesenner, H. (2014). Epigenetic effects of natural polyphenols: a focus on SIRT1-mediated mechanisms. Mol. Nutr. Food Res. 58, 22-32.
7. Barger, J. L., Kayo, T., Vann, J. M., Arias, E. B., Wang, J., Hacker, T. A., Wang, Y., Raederstorff, D., Morrow, J. D., Leeuwenburgh, C. et al. (2008). A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS ONE 3, e2264.
8. Barh, D., Malhotra, R., Ravi, B. and Sindhurani, P. (2010). MicroRNA let-7: an emerging next-generation cancer therapeutic. Curr. Oncol. 17, 70-80.
9. Barlev, N. A., Liu, L., Chehab, N. H., Mansfield, K., Harris, K. G., Halazonetis, T. D. and Berger, S. L. (2001). Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol. Cell 8, 1243-1254.
10. Barnes, S. (1995). Effect of genistein on in vitro and in vivo models of cancer. J. Nutr. 125 Suppl., 777S-783S.
11. Baur, J. A., Ungvari, Z., Minor, R. K., Le Couteur, D. G. and de Cabo, R. (2012). Are sirtuins viable targets for improving healthspan and lifespan? Nat. Rev. Drug Discov. 11, 443-461.
12. Baylin, S. B. and Ohm, J. E. (2006). Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6, 107-116.
13. Bazarov, A. V., Van Sluis, M., Hines, W. C., Bassett, E., Beliveau, A., Campeau, E., Mukhopadhyay, R., Lee, W. J., Melodyev, S., Zaslavsky, Y. et al. (2010). p16(INK4a)-mediated suppression of telomerase in normal and malignant human breast cells. Aging Cell 9, 736-746.
14. Berletch, J. B., Liu, C., Love, W. K., Andrews, L. G., Katiyar, S. K. and Tollefsbol, T. O. (2008). Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J. Cell. Biochem. 103, 509-519.
15. Bestor, T. H. (2000). The DNA methyltransferases of mammals. Hum. Mol. Genet. 9, 2395-2402.
16. Bordone, L. and Guarente, L. (2005). Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat. Rev. Mol. Cell Biol. 6, 298-305.
17. Boros, L. G., Bassilian, S., Lim, S. and Lee, W. N. (2001). Genistein inhibits nonoxidative ribose synthesis in MIA pancreatic adenocarcinoma cells: a new mechanism of controlling tumor growth. Pancreas 22, 1-7.
18. Borra, M. T., Smith, B. C. and Denu, J. M. (2005). Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 280, 17187-17195.
19. Brosh, R. and Rotter, V. (2009). When mutants gain new powers: news from the mutant p53 field. Nat. Rev. Cancer 9, 701-713.
20. Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y. et al. (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015.
21. Chen, D. C., Chung, Y. F., Yeh, Y. T., Chaung, H. C., Kuo, F. C., Fu, O. Y., Chen, H. Y., Hou, M. F. and Yuan, S. S. (2006). Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett. 237, 109-114.
22. Chen, Y., Zaman, M. S., Deng, G., Majid, S., Saini, S., Liu, J., Tanaka, Y. and Dahiya, R. (2011). MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev. Res. (Phila.) 4, 76-86.
23. Chen, Y. W., Kao, S. Y., Wang, H. J. and Yang, M. H. (2013). Histone modification patterns correlate with patient outcome in oral squamous cell carcinoma. Cancer 119, 4259-4267.
24. Chervona, Y. and Costa, M. (2012). Histone modifications and cancer: biomarkers of prognosis? Am J Cancer Res 2, 589-597.
25. Choi, S. W. and Friso, S. (2010). Epigenetics: a new bridge between nutrition and health. Adv. Nutr. 1, 8-16.
26. Choi, J. D. and Lee, J. S. (2013). Interplay between epigenetics and genetics in cancer. Genomics Inform 11, 164-173.
27. Clayton, A. L., Hazzalin, C. A. and Mahadevan, L. C. (2006). Enhanced histone acetylation and transcription: a dynamic perspective. Mol. Cell 23, 289-296.
28. Cleary, M. P., Ray, A., Rogozina, O. P., Dogan, S. and Grossmann, M. E. (2009). Targeting the adiponectin:leptin ratio for postmenopausal breast cancer prevention. Front. Biosci. (Schol. Ed.) 1, 329-357.
29. Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W. et al. (2009). Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325, 201-204.
30. Cooks, T., Pateras, I. S., Tarcic, O., Solomon, H., Schetter, A. J., Wilder, S., Lozano, G., Pikarsky, E., Forshew, T., Rosenfeld, N. et al. (2013). Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammationassociated colorectal cancer. Cancer Cell 23, 634-646.
31. Cruzen, C. and Colman, R. J. (2009). Effects of caloric restriction on cardiovascular aging in non-human primates and humans. Clin. Geriatr. Med. 25, 733-743, ix-x.
32. Dai, C. Y. and Enders, G. H. (2000). p16 INK4a can initiate an autonomous senescence program. Oncogene 19, 1613-1622.
33. Daniel, M., Peek, G. W. and Tollefsbol, T. O. (2012). Regulation of the human catalytic subunit of telomerase (hTERT). Gene 498, 135-146.
34. Das, P. M. and Singal, R. (2004). DNA methylation and cancer. J. Clin. Oncol. 22, 4632-4642.
35. Dashwood, R. H. and Ho, E. (2008). Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanates. Nutr. Rev. 66 Suppl. 1, S36-S38.
36. Dickson, M. A., Hahn, W. C., Ino, Y., Ronfard, V., Wu, J. Y., Weinberg, R. A., Louis, D. N., Li, F. P. and Rheinwald, J. G. (2000). Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 20, 1436-1447.
37. Duenas-Gonzalez, A., Lizano, M., Candelaria, M., Cetina, L., Arce, C. and Cervera, E. (2005). Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol. Cancer 4, 38.
38. Elsheikh, S. E., Green, A. R., Rakha, E. A., Powe, D. G., Ahmed, R. A., Collins, H. M., Soria, D., Garibaldi, J. M., Paish, C. E., Ammar, A. A. et al. (2009). Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res. 69, 3802-3809.
39. Ezaki, J., Matsumoto, N., Takeda-Ezaki, M., Komatsu, M., Takahashi, K., Hiraoka, Y., Taka, H., Fujimura, T., Takehana, K., Yoshida, M. et al. (2011). Liver autophagy contributes to the maintenance of blood glucose and amino acid levels. Autophagy 7, 727-736.
40. Fang, M. Z., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W. and Yang, C. S. (2003). Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 63, 7563-7570.
41. Fang, M. Z., Chen, D., Sun, Y., Jin, Z., Christman, J. K. and Yang, C. S. (2005). Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin. Cancer Res. 11, 7033-7041.
42. Feinberg, A. P. and Vogelstein, B. (1983). Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89-92.
43. Ferdin, J., Kunej, T. and Calin, G. A. (2010). Non-coding RNAs: identification of cancer-associated microRNAs by gene profiling. Technol. Cancer Res. Treat. 9, 123-138.
44. Fimognari, C., Lenzi, M. and Hrelia, P. (2008). Chemoprevention of cancer by isothiocyanates and anthocyanins: mechanisms of action and structure-activity relationship. Curr. Med. Chem. 15, 440-447.
45. Fontana, L. and Klein, S. (2007). Aging, adiposity, and calorie restriction. JAMA 297, 986-994.
46. Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K. et al. (2005). Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37, 391-400.
47. Freed-Pastor, W. A. and Prives, C. (2012). Mutant p53: one name, many proteins. Genes Dev. 26, 1268-1286.
48. Gallagher, E. J., Fierz, Y., Ferguson, R. D. and LeRoith, D. (2010). The pathway from diabetes and obesity to cancer, on the route to targeted therapy. Endocr. Pract. 16, 864-873.
49. Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H. and Jaenisch, R. (2003). Induction of tumors in mice by genomic hypomethylation. Science 300, 489-492.
50. Giannakou, M. E. and Partridge, L. (2004). The interaction between FOXO and SIRT1: tipping the balance towards survival. Trends Cell Biol. 14, 408-412.
51. Gil, J. and Peters, G. (2006). Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol. 7, 667-677.
52. Greco, T., Shafer, J. and Fiskum, G. (2011). Sulforaphane inhibits mitochondrial permeability transition and oxidative stress. Free Radic. Biol. Med. 51, 2164-2171.
53. Greer, E. L. and Brunet, A. (2008). FOXO transcription factors in ageing and cancer. Acta Physiol. (Oxf.) 192, 19-28.
54. Guerrero-Preston, R., Santella, R. M., Blanco, A., Desai, M., Berdasco, M. and Fraga, M. (2007). Global DNA hypomethylation in liver cancer cases and controls: a phase I preclinical biomarker development study. Epigenetics 2, 223-226.
55. Halkidou, K., Gaughan, L., Cook, S., Leung, H. Y., Neal, D. E. and Robson, C. N. (2004). Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 59, 177-189.
56. Hardy, T. M. and Tollefsbol, T. O. (2011). Epigenetic diet: impact on the epigenome and cancer. Epigenomics 3, 503-518.
57. Harper, J. M., Leathers, C. W. and Austad, S. N. (2006). Does caloric restriction extend life in wild mice? Aging Cell 5, 441-449.
58. Harvey, A. E., Lashinger, L. M. and Hursting, S. D. (2011). The growing challenge of obesity and cancer: an inflammatory issue. Ann. N. Y. Acad. Sci. 1229, 45-52.
59. Harvey, A. E., Lashinger, L. M., Otto, G., Nunez, N. P. and Hursting, S. D. (2013). Decreased systemic IGF-1 in response to calorie restriction modulates murine tumor cell growth, nuclear factor-ÈB activation, and inflammation-related gene expression. Mol. Carcinog. 52, 997-1006.
60. Hass, B. S., Hart, R. W., Lu, M. H. and Lyn-Cook, B. D. (1993). Effects of caloric restriction in animals on cellular function, oncogene expression, and DNA methylation in vitro. Mutat. Res. 295, 281-289.
61. Hawkins, P. G. and Morris, K. V. (2008). RNA and transcriptional modulation of gene expression. Cell Cycle 7, 602-607.
62. Herceg, Z. (2007). Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 22, 91-103.
63. Holloszy, J. O. and Fontana, L. (2007). Caloric restriction in humans. Exp. Gerontol. 42, 709-712.
64. Hon, G. C., Hawkins, R. D. and Ren, B. (2009). Predictive chromatin signatures in the mammalian genome. Hum. Mol. Genet. 18, R195-R201.
65. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L. L. et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196.
66. Huffman, K. (2012). The developing, aging neocortex: how genetics and epigenetics influence early developmental patterning and age-related change. Front. Genet. 3, 212.
67. Hursting, S. D., Smith, S. M., Lashinger, L. M., Harvey, A. E. and Perkins, S. N. (2010). Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis 31, 83-89.
68. Hursting, S. D., Dunlap, S. M., Ford, N. A., Hursting, M. J. and Lashinger, L. M. (2013). Calorie restriction and cancer prevention: a mechanistic perspective. Cancer Metab 1, 10.
69. IARC (2008). Cancer incidence in five continents. IARC Sci. Publ. IX, 1-837.
70. Johnston, K., Sharp, P., Clifford, M. and Morgan, L. (2005). Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett. 7, 1653-1657.
71. Kagawa, Y. (1978). Impact of Westernization on the nutrition of Japanese: changes in physique, cancer, longevity and centenarians. Prev. Med. 7, 205-217.
72. Kapahi, P., Chen, D., Rogers, A. N., Katewa, S. D., Li, P. W., Thomas, E. L. and Kockel, L. (2010). With TOR, less is more: a key role for the conserved nutrientsensing TOR pathway in aging. Cell Metab. 11, 453-465.
73. Khaw, A. K., Yong, J. W., Kalthur, G. and Hande, M. P. (2012). Genistein induces growth arrest and suppresses telomerase activity in brain tumor cells. Genes Chromosomes Cancer 51, 961-974.
74. Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A. and Klingelhutz, A. J. (1998). Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88.
75. Klaus, S., Pultz, S., Thone-Reineke, C. and Wolfram, S. (2005). Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int. J. Obes. 29, 615-623.
76. Knapowski, J., Wieczorowska-Tobis, K. and Witowski, J. (2002). Pathophysiology of ageing. J. Physiol. Pharmacol. 53, 135-146.
77. Koki, A., Khan, N. K., Woerner, B. M., Dannenberg, A. J., Olson, L., Seibert, K., Edwards, D., Hardy, M., Isakson, P. and Masferrer, J. L. (2002). Cyclooxygenase-2 in human pathological disease. Adv. Exp. Med. Biol. 507, 177-184.
78. Koubova, J. and Guarente, L. (2003). How does calorie restriction work? Genes Dev. 17, 313-321.
79. Kouzarides, T. (2007). Chromatin modifications and their function. Cell 128, 693-705.
80. Kyo, S., Takakura, M., Fujiwara, T. and Inoue, M. (2008). Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci. 99, 1528-1538.
81. Lanvin, O., Bianco, S., Kersual, N., Chalbos, D. and Vanacker, J. M. (2007). Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790. J. Biol. Chem. 282, 28328-28334.
82. Li, Y. and Tollefsbol, T. O. (2010). Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr. Med. Chem. 17, 2141-2151.
83. Li, Y. and Tollefsbol, T. O. (2011). p16(INK4a) suppression by glucose restriction contributes to human cellular lifespan extension through SIRT1-mediated epigenetic and genetic mechanisms. PLoS ONE 6, e17421.
84. Li, E., Beard, C. and Jaenisch, R. (1993). Role for DNA methylation in genomic imprinting. Nature 366, 362-365.
85. Li, Y., Liu, L. and Tollefsbol, T. O. (2010a). Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression. FASEB J. 24, 1442-1453.
86. Li, Y., Yuan, Y. Y., Meeran, S. M. and Tollefsbol, T. O. (2010b). Synergistic epigenetic reactivation of estrogen receptor-(ER) by combined green tea polyphenol and histone deacetylase inhibitor in ER-negative breast cancer cells. Mol. Cancer 9, 274.
87. Li, Y., Daniel, M. and Tollefsbol, T. O. (2011). Epigenetic regulation of caloric restriction in aging. BMC Med. 9, 98.
88. Li, Y., Meeran, S. M., Patel, S. N., Chen, H., Hardy, T. M. and Tollefsbol, T. O. (2013). Epigenetic reactivation of estrogen receptor-(ER) by genistein enhances hormonal therapy sensitivity in ER-negative breast cancer. Mol. Cancer 12, 9.
89. Liao, C. Y., Rikke, B. A., Johnson, T. E., Diaz, V. and Nelson, J. F. (2010). Genetic variation in the murine lifespan response to dietary restriction: from life extension to life shortening. Aging Cell 9, 92-95.
90. Liao, Y. P., Chen, L. Y., Huang, R. L., Su, P. H., Chan, M. W., Chang, C. C., Yu, M. H., Wang, P. H., Yen, M. S., Nephew, K. P. et al. (2014). Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients. Hum. Mol. Genet. 23, 1894-1906.
91. Lin, J. K., Liang, Y. C. and Lin-Shiau, S. Y. (1999). Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem. Pharmacol. 58, 911-915.
92. Lin, C. H., Hsieh, S. Y., Sheen, I. S., Lee, W. C., Chen, T. C., Shyu, W. C. and Liaw, Y. F. (2001). Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res. 61, 4238-4243.
93. Link, A., Balaguer, F. and Goel, A. (2010). Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem. Pharmacol. 80, 1771-1792.
94. Liu, P. L., Tsai, J. R., Charles, A. L., Hwang, J. J., Chou, S. H., Ping, Y. H., Lin, F. Y., Chen, Y. L., Hung, C. Y., Chen, W. C. et al. (2010). Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases. Mol. Nutr. Food Res. 54 Suppl. 2, S196-S204.
95. Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F. and Richmond, T. J. (1997). Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251-260.
96. Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setién, F., Casado, S., Suarez-Gauthier, A., Sanchez-Cespedes, M., Git, A. et al. (2007). Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67, 1424-1429.
97. Mao, Q. Q., Bai, Y., Lin, Y. W., Zheng, X. Y., Qin, J., Yang, K. and Xie, L. P. (2010). Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines. Mol. Nutr. Food Res. 54, 1574-1584.
98. Martin, S. L., Hardy, T. M. and Tollefsbol, T. O. (2013). Medicinal chemistry of the epigenetic diet and caloric restriction. Curr. Med. Chem. 20, 4050-4059.
99. Mathers, J. C., Strathdee, G. and Relton, C. L. (2010). Induction of epigenetic alterations by dietary and other environmental factors. Adv. Genet. 71, 3-39.
100. Mattison, J. A., Roth, G. S., Beasley, T. M., Tilmont, E. M., Handy, A. M., Herbert, R. L., Longo, D. L., Allison, D. B., Young, J. E., Bryant, M. et al. (2012). Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 489, 318-321.
101. McCay, C. M., Crowell, M. F. and Maynard, L. A. (1989). The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition 5, 155-171, discussion 172.
102. Meeran, S. M., Patel, S. N. and Tollefsbol, T. O. (2010). Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS ONE 5, e11457.
103. Mercken, E. M., Crosby, S. D., Lamming, D. W., JeBailey, L., Krzysik-Walker, S., Villareal, D. T., Capri, M., Franceschi, C., Zhang, Y., Becker, K. et al. (2013). Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile. Aging Cell 12, 645-651.
104. Mercken, E. M., Hu, J., Krzysik-Walker, S., Wei, M., Li, Y., McBurney, M. W., de Cabo, R. and Longo, V. D. (2014). SIRT1 but not its increased expression is essential for lifespan extension in caloric-restricted mice. Aging Cell 13, 193-196.
105. Messina, M., McCaskill-Stevens, W. and Lampe, J. W. (2006). Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J. Natl. Cancer Inst. 98, 1275-1284.
106. Michels, K. B. and Ekbom, A. (2004). Caloric restriction and incidence of breast cancer. JAMA 291, 1226-1230.
107. Milenkovic, D., Deval, C., Gouranton, E., Landrier, J. F., Scalbert, A., Morand, C. and Mazur, A. (2012). Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols. PLoS ONE 7, e29837.
108. Montgomery, M. K., Xu, S. and Fire, A. (1998). RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 95, 15502-15507.
109. Morton, J. P., Timpson, P., Karim, S. A., Ridgway, R. A., Athineos, D., Doyle, B., Jamieson, N. B., Oien, K. A., Lowy, A. M., Brunton, V. G. et al. (2010). Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc. Natl. Acad. Sci. USA 107, 246-251.
110. Muñoz-Najar, U. and Sedivy, J. M. (2011). Epigenetic control of aging. Antioxid. Redox Signal. 14, 241-259.
111. Murphy, M., Ahn, J., Walker, K. K., Hoffman, W. H., Evans, R. M., Levine, A. J. and George, D. L. (1999). Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev. 13, 2490-2501.
112. Nadal-Serrano, M., Pons, D. G., Sastre-Serra, J., Blanquer-Rosselló, M. M., Roca, P. and Oliver, J. (2013). Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes. Int. J. Biochem. Cell Biol. 45, 2045-2051.
113. Narita, M., N͡nez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J. and Lowe, S. W. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716.
114. Olivier, M., Langerød, A., Carrieri, P., Bergh, J., Klaar, S., Eyfjord, J., Theillet, C., Rodriguez, C., Lidereau, R., Bièche, I. et al. (2006). The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin. Cancer Res. 12, 1157-1167.
115. Ono, M. (2008). Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 99, 1501-1506.
116. Ouchi, H., Ishiguro, H., Ikeda, N., Hori, M., Kubota, Y. and Uemura, H. (2005). Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity. Int. J. Urol. 12, 73-80.
117. Pearson, K. J., Baur, J. A., Lewis, K. N., Peshkin, L., Price, N. L., Labinskyy, N., Swindell, W. R., Kamara, D., Minor, R. K., Perez, E. et al. (2008). Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 8, 157-168.
118. Perabo, F. G., Von Löw, E. C., Ellinger, J., von Rücker, A., Müller, S. C. and Bastian, P. J. (2008). Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis. 11, 6-12.
119. Pericleous, M., Mandair, D. and Caplin, M. E. (2013). Diet and supplements and their impact on colorectal cancer. J. Gastrointest. Oncol. 4, 409-423.
120. Pons, D. G., Nadal-Serrano, M., Blanquer-Rossello, M. M., Sastre-Serra, J., Oliver, J. and Roca, P. (2014). Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio. J. Cell. Biochem. 115, 949-958.
121. Prives, C. and White, E. (2008). Does control of mutant p53 by Mdm2 complicate cancer therapy? Genes Dev. 22, 1259-1264.
122. Qin, W., Zhu, W., Shi, H., Hewett, J. E., Ruhlen, R. L., MacDonald, R. S., Rottinghaus, G. E., Chen, Y. C. and Sauter, E. R. (2009). Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women. Nutr. Cancer 61, 238-244.
123. Razin, A. and Riggs, A. D. (1980). DNA methylation and gene function. Science 210, 604-610.
124. Rebrin, I., Kamzalov, S. and Sohal, R. S. (2003). Effects of age and caloric restriction on glutathione redox state in mice. Free Radic. Biol. Med. 35, 626-635.
125. Renaud, S., Loukinov, D., Abdullaev, Z., Guilleret, I., Bosman, F. T., Lobanenkov, V. and Benhattar, J. (2007). Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res. 35, 1245-1256.
126. Ribarič, S. (2012). Diet and aging. Oxid. Med. Cell. Longev. 2012, 741468.
127. Rivlin, N., Brosh, R., Oren, M. and Rotter, V. (2011). Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Genes Cancer 2, 466-474.
128. Rodriguez, O. C., Choudhury, S., Kolukula, V., Vietsch, E. E., Catania, J., Preet, A., Reynoso, K., Bargonetti, J., Wellstein, A., Albanese, C. et al. (2012). Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy. Cell Cycle 11, 4436-4446.
129. Rohren, E. M., Turkington, T. G. and Coleman, R. E. (2004). Clinical applications of PET in oncology. Radiology 231, 305-332.
130. Ross, S. A. and Davis, C. D. (2011). MicroRNA, nutrition, and cancer prevention. Adv Nutr 2, 472-485.
131. Ross, S. A., Dwyer, J., Umar, A., Kagan, J., Verma, M., Van Bemmel, D. M. and Dunn, B. K. (2008). Introduction: diet, epigenetic events and cancer prevention. Nutr. Rev. 66 Suppl. 1, S1-S6.
132. Roth, G. S., Ingram, D. K. and Lane, M. A. (2001). Caloric restriction in primates and relevance to humans. Ann. N. Y. Acad. Sci. 928, 305-315.
133. Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A. and Jones, P. A. (2006). Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9, 435-443.
134. Seibel, J., Molzberger, A. F., Hertrampf, T., Laudenbach-Leschowski, U. and Diel, P. (2009). Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis. Eur. J. Nutr. 48, 213-220.
135. Serrano, M., Hannon, G. J. and Beach, D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
136. Shanmugam, M. K., Kannaiyan, R. and Sethi, G. (2011). Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr. Cancer 63, 161-173.
137. Shao, G., Balajee, A. S., Hei, T. K. and Zhao, Y. (2008). p16INK4a downregulation is involved in immortalization of primary human prostate epithelial cells induced by telomerase. Mol. Carcinog. 47, 775-783.
138. Sharpless, N. E. (2005). INK4a/ARF: a multifunctional tumor suppressor locus. Mutat. Res. 576, 22-38.
139. Siddiqui, I. A., Asim, M., Hafeez, B. B., Adhami, V. M., Tarapore, R. S. and Mukhtar, H. (2011). Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J. 25, 1198-1207.
140. Simon, C., Chagraoui, J., Krosl, J., Gendron, P., Wilhelm, B., Lemieux, S., Boucher, G., Chagnon, P., Drouin, S., Lambert, R. et al. (2012). A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev. 26, 651-656.
141. Singhal, R. P., Mays-Hoopes, L. L. and Eichhorn, G. L. (1987). DNA methylation in aging of mice. Mech. Ageing Dev. 41, 199-210.
142. Sohal, R. S. and Weindruch, R. (1996). Oxidative stress, caloric restriction, and aging. Science 273, 59-63.
143. Song, J., Noh, J. H., Lee, J. H., Eun, J. W., Ahn, Y. M., Kim, S. Y., Lee, S. H., Park, W. S., Yoo, N. J., Lee, J. Y. et al. (2005). Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS 113, 264-268.
144. Stefanska, B., Rudnicka, K., Bednarek, A. and Fabianowska-Majewska, K. (2010). Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells. Eur. J. Pharmacol. 638, 47-53.
145. Sun, Q., Cong, R., Yan, H., Gu, H., Zeng, Y., Liu, N., Chen, J. and Wang, B. (2009). Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncol. Rep. 22, 563-567.
146. Tan, Y., Zhang, B., Wu, T., Skogerbø, G., Zhu, X., Guo, X., He, S. and Chen, R. (2009). Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human breast cancer cells. BMC Mol. Biol. 10, 12.
147. Tasdemir, E., Chiara Maiuri, M., Morselli, E., Criollo, A., D'Amelio, M., Djavaheri-Mergny, M., Cecconi, F., Tavernarakis, N. and Kroemer, G. (2008). A dual role of p53 in the control of autophagy. Autophagy 4, 810-814.
148. Telang, U., Brazeau, D. A. and Morris, M. E. (2009). Comparison of the effects of phenethyl isothiocyanate and sulforaphane on gene expression in breast cancer and normal mammary epithelial cells. Exp. Biol. Med. (Maywood) 234, 287-295.
149. Tlsty, T. D., Crawford, Y. G., Holst, C. R., Fordyce, C. A., Zhang, J., McDermott, K., Kozakiewicz, K. and Gauthier, M. L. (2004). Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis. J. Mammary Gland Biol. Neoplasia 9, 263-274.
150. Tollefsbol, T. O. (2014). Dietary epigenetics in cancer and aging. Cancer Treat. Res. 159, 257-267.
151. Tsang, W. P. and Kwok, T. T. (2010). Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J. Nutr. Biochem. 21, 140-146.
152. Tsou, J. A., Hagen, J. A., Carpenter, C. L. and Laird-Offringa, I. A. (2002). DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 21, 5450-5461.
153. Tu, S. H., Ku, C. Y., Ho, C. T., Chen, C. S., Huang, C. S., Lee, C. H., Chen, L. C., Pan, M. H., Chang, H. W., Chang, C. H. et al. (2011). Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine-and estrogen-induced α9-nicotinic acetylcholine receptor upregulation in human breast cancer cells. Mol. Nutr. Food Res. 55, 455-466.
154. Turturro, A., Witt, W. W., Lewis, S., Hass, B. S., Lipman, R. D. and Hart, R. W. (1999). Growth curves and survival characteristics of the animals used in the biomarkers of aging program. J. Gerontol. A Biol. Sci. Med. Sci. 54, B492-B501.
155. Valenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L. and Cellerino, A. (2006). Resveratrol prolongs lifespan and retards the onset of agerelated markers in a short-lived vertebrate. Curr. Biol. 16, 296-300.
156. Valls, J., Millán, S., Martí, M. P., Borràs, E. and Arola, L. (2009). Advanced separation methods of food anthocyanins, isoflavones and flavanols. J. Chromatogr. A 1216, 7143-7172.
157. Vanamala, J., Reddivari, L., Radhakrishnan, S. and Tarver, C. (2010). Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer 10, 238.
158. Vera, E., Bernardes de Jesus, B., Foronda, M., Flores, J. M. and Blasco, M. A. (2013). Telomerase reverse transcriptase synergizes with calorie restriction to increase health span and extend mouse longevity. PLoS ONE 8, e53760.
159. Vrba, L., Junk, D. J., Novak, P. and Futscher, B. W. (2008). p53 induces distinct epigenetic states at its direct target promoters. BMC Genomics 9, 486.
160. Waddington, C. H. (2012). The epigenotype. Int. J. Epidemiol. 41, 10-13.
161. Waki, T., Tamura, G., Sato, M. and Motoyama, T. (2003). Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene 22, 4128-4133.
162. Wang, R. H., Zheng, Y., Kim, H. S., Xu, X., Cao, L., Luhasen, T., Lee, M. H., Xiao, C., Vassilopoulos, A., Chen, W. et al. (2008). Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Mol. Cell 32, 11-20.
163. Warburg, O. (1956). On the origin of cancer cells. Science 123, 309-314.
164. Willcox, B. J., Willcox, D. C., Todoriki, H., Fujiyoshi, A., Yano, K., He, Q., Curb, J. D. and Suzuki, M. (2007). Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world's longest-lived people and its potential impact on morbidity and life span. Ann. N. Y. Acad. Sci. 1114, 434-455.
165. Wilson, V. L., Smith, R. A., Ma, S. and Cutler, R. G. (1987). Genomic 5-methyldeoxycytidine decreases with age. J. Biol. Chem. 262, 9948-9951.
166. Yang, X., Yan, L. and Davidson, N. E. (2001). DNA methylation in breast cancer. Endocr. Relat. Cancer 8, 115-127.
167. Yang, N., Coukos, G. and Zhang, L. (2008). MicroRNA epigenetic alterations in human cancer: one step forward in diagnosis and treatment. Int. J. Cancer 122, 963-968.
168. Yang, B., Sun, H., Lin, W., Hou, W., Li, H., Zhang, L., Li, F., Gu, Y., Song, Y., Li, Q. et al. (2013). Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry. Urol. Oncol. 31, 628-634.
169. Yun, J., Rago, C., Cheong, I., Pagliarini, R., Angenendt, P., Rajagopalan, H., Schmidt, K., Willson, J. K., Markowitz, S., Zhou, S. et al. (2009). Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325, 1555-1559.
170. Zhao, Y., Deng, C., Wang, J., Xiao, J., Gatalica, Z., Recker, R. R. and Xiao, G. G. (2011). Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast Cancer Res. Treat. 127, 69-80.